RenovoRx (RNXT)
(Delayed Data from NSDQ)
$1.20 USD
-0.02 (-1.64%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $1.20 0.00 (0.00%) 7:56 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, RenovoRx, Inc. has a market cap of $44.62M, which represents its share price of $1.22 multiplied by its outstanding shares number of 36.57M. As a small-cap company, RNXT's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
RNXT 1.20 -0.02(-1.64%)
Will RNXT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for RNXT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RNXT
RenovoRx, Inc. (RNXT) Reports Q1 Loss, Lags Revenue Estimates
RNXT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for RNXT
RenovoRx expands commercialization for RenovoCath, announces leadership hire
RenovoRx to Host Second Quarter 2025 Financial Results and Business Highlights Conference Call ...
12 Health Care Stocks Moving In Friday's After-Market Session